Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
The CRISPR segment is estimated to grow at the highest CAGR during the forecast period.
In 2018, the global Genome Editing/Genome Engineering market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Genome Editing/Genome Engineering status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genome Editing/Genome Engineering development in United States, Europe and China.
The key players covered in this study
Thermo Fisher Scientific
Integrated Dna Technologies
New England Biolabs
Market segment by Type, the product can be split into
Market segment by Application, split into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Genome Editing/Genome Engineering status, future forecast, growth opportunity, key market and key players.
To present the Genome Editing/Genome Engineering development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Genome Editing/Genome Engineering are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.